Swett C
Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Waltham, Massachusetts 02154, USA.
Dis Nerv Syst. 1974 Nov;35(11):509-11.
In 470 consecutively monitored psychiatric inpatients who received chlorpromazine, adverse reactions attributed to the drug were reported in 150 (31.9%); and in three, the reaction was considered life-threatening (0.6%). Reactions were more frequent with higher daily doses and the intramuscular route was associated with earlier onset of a reaction.
在470名连续接受氯丙嗪监测的精神科住院患者中，有150名（31.9%）报告了归因于该药物的不良反应；其中有3例反应被认为危及生命（0.6%）。不良反应在每日剂量较高时更频繁出现，且肌肉注射途径与反应更早出现有关。
